Arcturus Therapeutics Holdings Inc (ARCT)
SG&A Expenses
$10.99M
Quarterly · Period ending: · USD
ARCT SG&A Expenses
Latest reported$10.99Mperiod ending
Latest reported$10.99Mperiod ending
ARCT Quarterly SG&A Expenses ($198.00K → $10.99M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ARCT sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 10,989,000 | |
| 8,807,000 | |
| 14,027,000 | |
| 10,398,000 | |
| 10,338,000 | |
| 11,315,000 | |
| 12,380,000 | |
| 13,276,000 | |
| 12,316,000 | |
| 14,851,000 | |
| 12,507,000 | |
| 13,377,000 | |
| 13,225,000 | |
| 13,762,000 | |
| 11,860,000 | |
| 12,488,000 | |
| 10,993,000 | |
| 10,730,000 | |
| 12,706,000 | |
| 10,860,000 | |
| 10,042,000 | |
| 9,743,000 | |
| 10,934,000 | |
| 5,572,000 | |
| 4,420,000 | |
| 4,191,000 | |
| 4,191,000 | |
| 3,881,000 | |
| 3,456,000 | |
| 3,534,000 | |
| 3,441,000 | |
| 3,810,000 | |
| 8,233,000 | |
| 5,098,000 | |
| 2,655,000 | |
| 1,646,000 | |
| 2,091,000 | |
| 1,180,000 | |
| 1,286,000 | |
| 1,211,000 | |
| 1,402,000 | |
| 1,458,000 | |
| 1,325,000 | |
| 1,176,000 | |
| 1,202,000 | |
| 1,289,000 | |
| 1,436,000 | |
| 1,266,000 | |
| 1,348,000 | |
| 1,789,000 | |
| 1,040,000 | |
| 1,069,000 | |
| 875,000 | |
| 239,000 | |
| 182,000 | |
| 145,000 | |
| 198,000 |